《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价一手中签率仅10%

AAFN2022-06-21

美因基因(06667.HK)公布招股结果，每股发售价定为18元，为招股价范围(18至22元)的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将於明日(22日)挂牌。独家保荐人为中信建投国际。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成後公司已发行股本约4.05%。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2245476311?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-06-21 08:41","share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","id":"2245476311","market":"us","top_or_hot":-1,"title":"《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价 一手中签率仅10%","media":"AAFN","content":"<div>\n<p>美因基因(06667.HK)公布招股结果，每股发售价定为18元，为招股价范围(18至22元)的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将於明日(22日)挂牌。独家保荐人为中信建投国际。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成後公司已发行股本约4.05%。...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1191853&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">网页链接</a>\n\n</div>\n","source":"aastocks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价 一手中签率仅10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价 一手中签率仅10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-21 08:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1191853&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美因基因(06667.HK)公布招股结果，每股发售价定为18元，为招股价范围(18至22元)的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将於明日(22日)挂牌。独家保荐人为中信建投国际。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成後公司已发行股本约4.05%。...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1191853&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1521","symbol_name":"挪威政府全球养老基金持仓","start_time":0,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1191853&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","article_id":"2245476311","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2245476311","pubTimestamp":1655772113,"sourceInfo":{"source_id":"aastocks","name":"阿思达克财经"},"weMediaInfo":null,"summary":"美因基因公布招股结果，每股发售价定为18元，为招股价范围的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将於明日挂牌。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成後公司已发行股本约4.05%。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1521":"挪威政府全球养老基金持仓","00388":"香港交易所","BK1131":"金融交易所和数据","06667":"美因基因","BK1589":"北水核心资产"},"translate_title":"[New share news] The public offering of Main Gene (06667. HK) is 8.6 times over-purchased and the lower limit 18 yuan pricing has a first-hand winning rate of only 10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00388":0.9,"06667":0.6},"content_text":"美因基因(06667.HK)公布招股结果，每股发售价定为18元，为招股价范围(18至22元)的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将於明日(22日)挂牌。独家保荐人为中信建投国际。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成後公司已发行股本约4.05%。公司是次上市料净集资约1.53亿元，拟将约30%用於消费级基因检测及癌症筛查服务及产品的销售、营销及商业化；约25%投资於研发我们的服务及产品；约20%用於增加或扩大检测能力及产能；约15%用於通过投资或收购与公司现有业务互补及协同的具吸引力的技术或检测相关公司；约10%用作营运资金及其他一般企业用途。(jl/s)~阿思达克财经新闻网址: www.aastocks.com","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2245476311"}

《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价 一手中签率仅10%

精彩评论

《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价一手中签率仅10%